Response to letter by Dr. Fathi and colleagues

Response to Letter by Dr. Cristina Brandolini

We appreciate the interest of Dr. Cristina Brandolini and coworkers in our paper on the audiovestibular loss of a vascular cause. We agree that vascular mechanisms and sensitivity to ischemic damage may differ between the vestibular and cochlear organs. In line with our previous report, they reported that cochlear symptoms, such as hearing loss and tinnitus, may be warning signs of an impending...

Response to Dr Kintz's letter.

In this letter, the author(s) propose(s) that 'the quantitative findings of zolpidem after a single exposure do not fit in with our daily experience' and that 'Given the risk of misinterpretation of the data of Cui et al., the authors see no reason to support the findings of the Chinese group'. Although markedly different from those reported by Villain et al. (1), the results appear. The method...

Response to letter to the editor by Dr. Cohen and Dr. Quintner.

Dear Editor, I appreciate the opportunity to respond to the letter to the editor of Drs. Cohen and Quintner (the authors), prompted by the reviewof theMuscle and Myofascial Pain section of the 2005 IASP Core Curriculum (IASP CC) [1]. The authors are acknowledged for their persistence in challenging inconsistencies in the constructs of the myofascial syndrome (and fibromyalgia). Indeed, and unfo...

Response to Dr. Edwin Yager's open letter to the editor.

Response to Bernardi and colleagues.

1. Damiens K, Ayoub JP, Lemieux B, et al. Clinical features and course of brain metastases in colorectal cancer: an experience from a single institution. Curr Oncol 2012;19:254–8. 2. Karam I, Hamilton S, Nichol A, et al. Population-based outcomes after brain radiotherapy in patients with brain metastases from breast cancer in the pre-trastuzumab and trastuzumab eras. Radiat Oncol 2013;8:12. [Av...